Monthly Archives: October 2013

Patent Expirations Creating Opportunities for Biotech M&A Large pharmaceutical companies with expired patents are looking for products to supplement their research and development efforts.  Hot areas appear to be in oncology names and autoimmune areas.  Although large pharmaceutical companies are facing one of the worst dilemmas with respect to patent expirations, they also have access […]